School of Medicine
Showing 141-150 of 173 Results
-
Kekoa Taparra, MD, PhD
Postdoctoral Medical Fellow, Radiation Therapy
Resident in Radiation Oncology - Radiation TherapyBioAloha, my name is Kekoa. I was born and raised in Mililani, Oʻahu, Hawaiʻi. My life’s mission has been to return home to the islands to provide high quality cancer care to the communities that raised me. I completed my PhD at Johns Hopkins School of Medicine and MD at Mayo Clinic Alix School of Medicine. I am currently a resident physician in the Department of Radiation Oncology at Stanford where I receive training in how to treat a variety of cancers. My research interests include Pacific Islander health disparities, "AAPI" health data disaggregation, water sustainability and climate resilient healthcare, access to cancer care disparities, and the impact of cancer healthcare costs have on survival outcomes. I was awarded the Inaugural 2023 ASCO Dr. Judith and Alan Kaur Endowed Young Investigator Award. My work has been published in The Lancet, JAMA, JNCI, and JCO Oncology Practice. I have been invited to speak on NHPI health at institutions including Harvard, MDACC Grand Rounds, UCLA, NIH/NCI, and the FDA. I serve as reviewer for a number of oncology journals including JCO, JNCI, JCO Oncology Practice, Cancers, IJROBP, and Cancer Epidemiology, Biomarkers & Prevention, among others. I was selected as a 2022-2023 American Society of Clinical Oncology Journals Editorial Fellow and a 2023-2024 Stanford Cancer Institute Fellow. I run a lab of more than 10 talented NHPI and NHPI-ally students across the nation who focus on elucidating NHPI health disparities that have been masked for decades. I welcome interdisciplinary collaborations to advance the health of our underserved Pacific Islander communities.
-
Lucas Kas Vitzthum, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Vitzthum is a radiation oncologist and clinical assistant professor of radiation oncology at Stanford University School of Medicine. He specializes in the treatment of gastrointestinal and thoracic cancers. He also has a clinical and research interest in oligometastatic cancer, which is cancer that has metastasized to a limited number of sites beyond its origin.
He began his career in biomedical engineering and is passionate about integrating new technologies to advance patient care.
Dr. Vitzthum delivers treatment personalized to each patient’s condition, overall health, and goals. He believes clear communication between doctor and patient is vital to help patients make informed care decisions.
His research interests include clinical trial development, survivorship, and predictive modeling to personalize patient treatment. He is especially interested in pursuing research that can address unmet clinical needs.
Dr. Vitzthum has received research support through the Radiological Society of North America, the American Society of Clinical Oncology’s Conquer Cancer Foundation, and the UCSD Altman Clinical and Translational Research Institute. His work has appeared in International Journal of Radiation Oncology Biology Physics, Annals of Oncology, JAMA Oncology, Clinical Cancer Research, and other publications.
He is a member of the American College of Radiation Oncology, American Society for Radiation Oncology, American Society of Clinical Oncology, and Radiologic Society of North America.
Dr. Vitzthum is also interested in improving access to high-quality cancer care for under-served populations domestically and abroad.
